EUVIMEDEUVIMED entdecken
Crossref

Discovery of HyT‐Based Degraders of CDK9‐Cyclin T1 Complex

Rongkun Lin, Jie Yang, Ting Liu, Mingyu Wang, Chongrong Ke, Cheng Luo, Jin Lin, Jiacheng Li, Hua Lin

Chemistry & Biodiversity · 2023-08 · 20 (8)

DOI: 10.1002/cbdv.202300769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 13.07.2023. Verfasst von Rongkun Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China. Hauptthemen laut MEDLINE: Cell Nucleus, Cyclins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Fujian Provincial Natural Science Foundation, National Key R&D Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct modulation of the non‐kinase functions of cyclin and CDK‐cyclin complexes poses challenges. We utilize hydrophobic tag (HyT) based small‐molecule degraders induced degradation of cyclin T1 and its corresponding kinase partner CDK9. LL‐CDK9‐12 demonstrated the most potent and selective degradation ability, with DC 50 values of 0.362 μM against CDK9 and 0.680 μM against cyclin T1. In prostate cancer cells, LL‐CDK9‐12 showed enhanced anti‐proliferative activity than its parental molecule SNS032 and LL‐K9‐3, the previous reported CDK9‐cyclin T1 degrader. Moreover, LL‐CDK9‐12 suppressed the downstream signaling of CDK9 and AR efficiently. Altogether, LL‐CDK9‐12 was an effective dual degrader of CDK9‐cyclin T1 and helped study the unknown function of CDK9‐cyclin T1. These results suggest that HyT‐based degraders could be used as a strategy to induce the degradation of protein complexes, providing insights for the design of protein complexes′ degraders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell NucleusCyclinsHumansMaleCell Cycle CheckpointsCyclin TProtein BindingCyclin-Dependent Kinase 9

Stichwörter der Autor:innen

CDK9cyclin T1degraderhydrophobic tagprotein degradation

Substanzen

Cyclin TCyclinsCDK9 protein, humanCyclin-Dependent Kinase 9CCNT1 protein, human

Autor:innen und Institutionen

  • School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
  • Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, 350117, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
  • National and Local United Engineering Research Center of Industrial Microbiology and Fermentation Technology, College of Life Sciences, Fujian Normal University, Fuzhou, 350117, Fujian, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528437, China.

Förderung

  • Fujian Provincial Natural Science Foundation
  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Lin, R., Yang, J., Liu, T., Wang, M., Ke, C., Luo, C., Lin, J., Li, J., & Lin, H. (2023). Discovery of HyT‐Based Degraders of CDK9‐Cyclin T1 Complex. Chemistry & Biodiversity, 20(8). https://doi.org/10.1002/cbdv.202300769

Vancouver

Lin R, Yang J, Liu T, Wang M, Ke C, Luo C, et al. Discovery of HyT‐Based Degraders of CDK9‐Cyclin T1 Complex. Chemistry & Biodiversity. 2023;20(8). doi:10.1002/cbdv.202300769

BibTeX
@article{Lin2023,
  author = {Lin, Rongkun and Yang, Jie and Liu, Ting and Wang, Mingyu and Ke, Chongrong and Luo, Cheng and Lin, Jin and Li, Jiacheng and Lin, Hua},
  title = {Discovery of HyT‐Based Degraders of CDK9‐Cyclin T1 Complex},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  volume = {20},
  number = {8},
  doi = {10.1002/cbdv.202300769}
}
Kostenlos starten →